EBioMedicine (Nov 2016)

Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic β Cells during Fasting and in Type 2 Diabetes

  • Shinji Kume,
  • Motoyuki Kondo,
  • Shiro Maeda,
  • Yoshihiko Nishio,
  • Tsuyoshi Yanagimachi,
  • Yukihiro Fujita,
  • Masakazu Haneda,
  • Keiko Kondo,
  • Akihiro Sekine,
  • Shin-ich Araki,
  • Hisazumi Araki,
  • Masami Chin-Kanasaki,
  • Satoshi Ugi,
  • Daisuke Koya,
  • Sawako Kitahara,
  • Kiyosumi Maeda,
  • Atsunori Kashiwagi,
  • Takashi Uzu,
  • Hiroshi Maegawa

DOI
https://doi.org/10.1016/j.ebiom.2016.10.038
Journal volume & issue
Vol. 13, no. C
pp. 168 – 180

Abstract

Read online

Glucose-stimulated insulin secretion (GSIS) by pancreatic β cells is biphasic. However, the physiological significance of biphasic GSIS and its relationship to diabetes are not yet fully understood. This study demonstrated that impaired first-phase GSIS follows fasting, leading to increased blood glucose levels and brain glucose distribution in humans. Animal experiments to determine a possible network between the brain and β cells revealed that fasting-dependent hyperactivation of AMP-activated protein kinase in the hypothalamus inhibited first-phase GSIS by stimulating the α-adrenergic pancreatic nerve. Furthermore, abnormal excitability of this brain-β cell neural axis was involved in diabetes-related impairment of first-phase GSIS in diabetic animals. Finally, pancreatic denervation improved first-phase GSIS and glucose tolerance and ameliorated severe diabetes by preventing β cell loss in diabetic animals. These results indicate that impaired first-phase GSIS is critical for brain distribution of dietary glucose after fasting. Furthermore, β cells in individuals with diabetes mistakenly sense that they are under conditions that mimic prolonged fasting. The present study provides additional insight into both β cell physiology and the pathogenesis of β cell dysfunction in type 2 diabetes.

Keywords